Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Biopharma Execs Go Face-To-Face With Obama Over TPP

This article was originally published in PharmAsia News

Executive Summary

President Barack Obama heard firsthand from a half dozen or so biopharmaceutical executives during an Oct. 8 White House face-to-face meeting about the industry's disappointment in the administration for agreeing to a minimum of five years of exclusivity protection for innovator biologics against biosimilars in the final TPP trade deal, rather than the 12 years required in the US by law.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC088496

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel